文献速递骨肌MR

伯明翰非典型软骨肿瘤影像学方案(BACTIP)再验证

Birmingham atypical cartilaginous tumour imaging protocol (BACTIP) revisited.
PubMed 文献 · Clin Radiol · 2025-02-05

研究纳入780例肱骨近端及膝关节周围(除外腓骨近端)孤立性中央软骨肿瘤患者,评估BACTIP分型与高级别软骨肉瘤的关系。结果显示BACTIP类型递增与恶性相关,III型中69%为高级别软骨肉瘤,恶变率仅0.4%且多发生在1年内;BACTIP仍是全科放射科医生判断需否转诊专科骨科肿瘤服务的实用工具。

要点

  • BACTIP类型递增与恶性相关:IA、IB、IIA型均为良性内生软骨瘤或非典型软骨肿瘤,III型中69%为高级别软骨肉瘤。
  • 仅4例随访MRI出现诊断延迟并进展为III型(IC型1例、IIB型3例),均在就诊7个月内识别为高级别软骨肉瘤。
  • 恶变罕见(0.4%)且倾向发生在相对早期(<1年)。

核心结论

  • BACTIP仍是全科放射科医生判断肱骨近端及膝关节周围中央软骨肿瘤是否需转诊专科骨科肿瘤服务的实用工具,未来在 borderline 病例转向「观察-扫描」策略时可能另有作用。

研究设计与样本

  • 结合回顾性与前瞻性研究,纳入2007至2016年专科骨科肿瘤单位评估的387例孤立性中央软骨肿瘤患者,并合并2017至2023年转诊的393例,共780例;评估初始及随访MRI的肿瘤头尾长度、骨内膜扇贝样改变或侵袭/恶性特征,按BACTIP分型并评估患者结局。

诊断标准与关键数值

  • BACTIP分型:IA、IB、IIA型病变均为良性内生软骨瘤或非典型软骨肿瘤;III型中69%诊断为高级别软骨肉瘤。
  • 随访MRI显示诊断延迟并进展为III型者共4例(IC型1例、IIB型3例),均在就诊7个月内识别为高级别软骨肉瘤。
  • 本组780例孤立性中央软骨肿瘤中高级别软骨肉瘤罕见(7%),恶变率0.4%且倾向发生在1年内。

临床应用与阅片要点

  • BACTIP可用于全科放射科医生判断肱骨近端及膝关节周围中央软骨肿瘤是否需转诊专科骨科肿瘤服务。
  • 随着 borderline 中央软骨肿瘤的管理偏好从手术干预转向「观察-扫描」策略,BACTIP未来可能另有作用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIM: To revalidate an MRI protocol for the management of solitary central cartilage tumours (CCTs) of the proximal humerus and around the knee, excluding the proximal fibula.

MATERIALS AND METHODS: Data on 387 patients with a solitary CCT assessed in a specialist orthopaedic oncology unit between 2007 and 2016 was updated and combined with a further 393 patients referred from 2017 to 2023. The initial MRI images and any follow-up scans were evaluated for craniocaudal length of the CCT, presence/absence of endosteal scalloping or aggressive/malignant features. The cases were categorised according to the BACTIP. Patient outcome was assessed to ascertain if the application of the protocol led to any delay in the diagnosis of high-grade chondrosarcoma (HGCS).

RESULTS: HGCS is rare (7%) in this large series of 780 patients with a solitary CCT. Ascending BACTIP type correlates with malignancy. All Type IA, IB, and IIA lesions were either benign enchondroma or atypical cartilaginous tumour (ACT), whereas 69% of Type III were diagnosed as HGCS. Only 4 cases on follow-up MRI showed a delay in diagnosis with progression to a BACTIP Type III (Type IC x1 and Type IIB x3). All were identified within seven months of presentation and were shown to be HGCS. Therefore, malignant transformation is remarkably rare (0.4%) and tends to occur relatively early (<1year).

CONCLUSION: This combined retrospective and prospective study confirms that BACTIP remains a useful tool for the general radiologist in determining which cases of CCT of the proximal humerus and around the knee would benefit from onward referral to a specialist orthopaedic oncology service. It may also have a further role in the future as management preferences for borderline CCTs move away from surgical intervention to a watch-and-scan policy.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Davies AM, Patel A, Azzopardi C, et al. Birmingham atypical cartilaginous tumour imaging protocol (BACTIP) revisited. Clin Radiol. 2025. PMID: 40056761. doi:10.1016/j.crad.2025.106837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。